Medicines/Supplements

Browse by Category

DES

Is Common MRI Contrast Dye Safe? What You Need to Know

Small amounts of gadolinium-based contrast agents (GBCAs) can remain in the body for a long time. It also said that “it is not known how GBCAs may affect you long term” and emphasized that “studies have not found any harmful effects in patients with normal kidney function.”

Med Given to Women 60 Years Ago Affects Granddaughters

DES Granddaughters have a higher risk of having a preterm birth delivery, irregular menstruation and of going at least six weeks without a period than other women in the population whose mothers were not DES Daughters, found a new study. The findings, published in late December in the journal Reproductive…

Now We Know: Endocrine Disruptors Affect Grandchildren

Can an endocrine disruptor in a pregnant woman cause ADHD in her grandchildren? A new study on DES says yes. How do you study the effects of a group of chemicals that surround us daily, affect us before our birth and cause a variety of damages? Endocrine disruptors are so…

Our Bodies, Ourselves and DES Action: 40 Years of Partnership

Fran Howell and Kari Christianson, members of MedShadow‘s sister site, DES Action USA, worked with Our Bodies, Ourselves to write the chapter on DES in OBOS in 2011. Here are their thoughts. By Fran Howell and Kari Christianson News that Our Bodies, Ourselves will no longer publish updated editions caught…

Moving DES From One Family’s Tragedy Into the National Spotlight

Judith Helfand, a documentary filmmaker, used her own experience as a DES daughter as the basis of a documentary to shed more light on the dangerous synthetic estrogen known as diethylstilbestrol. “A mother took a drug to have a baby. And now that baby can’t have a baby because she…

Lessons For the Future, From 60 Years Ago

The tragedy of DES began 60 years ago as pregnant women took the synthetic estrogen that had dangerous side effects. But lessons have been learned. Sixty years ago, obstetricians were busy prescribing a damaging drug to pregnant women called DES (diethylstilbestrol). It was on the market for 31 years before…

MedShadow Partners with DES Action

Today MedShadow Foundation signed a contract to acquire DES Action USA. Starting February 2015 MedShadow Foundation will take on the continuing responsibility for educating the world about DES (diethylstilbestrol) — the world’s first synthetic estrogen and endocrine disruptor. We at MedShadow don’t take this responsibility lightly. DES Action, founded in…

MedShadow Foundation to Welcome DES Action USA Under Umbrella

NEW YORK CITY, NY, December 2, 2014 – MedShadow Foundation, a nonprofit online advocacy source that educates consumers on the side effects of prescription medications, today announced it is merging with DES Action USA, a nonprofit advocacy organization that provides information and educational resources to individuals exposed to the harmful…

I Want to Trust My Medicines…

… But, sadly, I don’t. As a DES daughter and as a mother who hasn’t received forthright answers on drugs prescribed for her son, I’m cautious. Through my own experience I’ve learned there are two issues: one is that a pharmaceutical company can market a drug before proving that the…

DES (Diethylstilbestrol)

DES is a synthetic estrogen, one of the first to be developed. In the early 1950s doctors started giving DES to pregnant women who had previously miscarried The theory was that women produce estrogen naturally and during pregnancy natural estrogen levels rise. Therefore, more estrogen would help a pregnancy. The practice…

Eli Lilly Pays for DES Damages…Again

A major win for DES daughters – Eli Lilly settled with the Melnick family on the claim that DES given to their mother during their four pregnancies caused the breast cancer that each of the four experienced between the ages of 47 and 52. The Melnick family was a test…

  • Advertisement